Supply Chain Integrity Reduces Threats of Counterfeit Drug Products

In a recent Flash Report, Rx-360.org offered a summary of the proposed USP Chapter 1083 – Good Distribution Practices – Supply Chain Integrity.  In its report, Rx-360 noted that “globalization of all aspects of the pharmaceutical business has driven the need to address the threats of counterfeit or adulterated medication, devices and components, for which [...]

The Price of Quality

The FDA initiated a framework to modernize the way pharmaceutical and biopharmaceutical products are developed, manufactured and used through the use of data and science-based decision making.  This was visualized when they published a concept paper on current Good Manufacturing Practices for the 21st century in mid-2002. This was followed by the International Conference on [...]